RCSI research has found that venetoclax, a medication currently approved for leukemia, has benefits for patients with multiple myeloma when used in combination with another drug.
Venetoclax combo opens new treatment path for incurable multiple myeloma
- Post author:
- Post published:
- Post category:uncategorized